Journal Logo

EDITORIAL INTRODUCTIONS

Editorial introductions

Editor(s): Harlan, David M.; Streja, Dan; Safer, Joshua D.

Current Opinion in Endocrinology & Diabetes and Obesity: April 2016 - Volume 23 - Issue 2 - p vi-vii
doi: 10.1097/MED.0000000000000252
  • Free

Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

SECTION EDITORS

David M. Harlan

David M. Harlan

Dr David M. Harlan is a graduate of the University of Michigan (Bachelor of Science) and the Duke University School of Medicine, USA. He completed his internal medicine internship and residency at the Duke University Medical Center. This was before serving for 4 years as a staff internist at the Navy Hospital, San Diego, CA, USA. He then returned to Duke for his fellowship training in diabetes, endocrinology, and metabolism.

In 1991 he established his laboratory at the Navy Medical Research Institute, USA, where he rose to become the Director of Combat Casualty Care. He was then appointed to the faculty of the Uniformed Services University of the Health Sciences. In 1999, he moved his laboratory to the National Institutes of Health, where he became the Diabetes Branch Chief within the National Institute of Diabetes, Digestive, and Kidney Diseases.

In 2010, he moved to the University of Massachusetts School of Medicine, USA, where he is the William and Doris Krupp Professor of Medicine. Dr Harlan co-directs the university's Diabetes Center of Excellence. His research interests all relate to diabetes and include the immunopathogenesis underlying type 1diabetes and improved care delivery models, including transplant-based approaches, for the disease.

Dan Streja

Dan Streja

Dr Dan Streja is Clinical Professor of Medicine at David Geffen School of Medicine at UCLA, Department of Medicine Section of Endocrinology.

Dr Streja received his MD from the Carol Davilla School of Medicine in Bucharest Romania. He trained in internal medicine in Canada and subsequently undertook a fellowship in Endocrinology sponsored by the Ontario Heart Foundation for studies in lipid metabolism. He taught Medicine and Physiology at the University of Manitoba where he was also director of the diabetes clinic. He moved to the United States in 1979 and taught at UCLA since. He is a member of the American Heart Association and of the American Diabetes Association, and he is a fellow of the Royal College of Physicians of Canada and of the American Association of Clinical Endocrinologists. His main scientific interest has been in clinical research, particularly in cardiovascular prevention for patients with diabetes. He has conducted over 150 randomized trials in the field of diabetes and lipids.

Dr Streja has authored chapters in five textbooks and co-authored numerous scientific publications. He has lectured in the area of lipids and cardiovascular prevention nationally, in the US, and internationally.

Joshua D. Safer

Joshua D. Safer

Joshua Safer is the Program director for the Endocrinology Fellowship at Boston University Medical Center, USA, the director of Endocrinology Education at Boston University School of Medicine, and Associate Professor of Medicine at the BU School of Medicine.

Dr Safer received his medical degree from the University of Wisconsin, USA. He completed his internal medicine residency at Beth Israel Medical Center in New York City, USA and his endocrinology fellowship at Beth Israel Deaconess Medical Center in Boston, USA.

Dr Safer is steering committee co-chair of the international transgender research consortium, TransNet, which seeks to develop national research strategy in transgender medicine. In addition, he is president of the Association of Specialty Professors, the umbrella organization for leaders in internal medicine subspecialty education. Dr Safer serves on the Endocrine Society task force that is revising guidelines for the medical care of transgender patients and on the Global Education Initiative committee for the World Professional Association for Transgender Health.

Dr Safer's research focus has been to demonstrate health and quality of life benefits accruing from increased access to care for transgender patients. His current and past sources of funding support include the NIH and a number of private foundations. Also, Dr Safer has been developing novel transgender medicine curricular content at the BU School of Medicine and is pursuing efforts to share them nationally.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.